The Pediatric Forum |

Herb-Drug Interaction Implications in Pediatric Practice: An Overview of Pharmacokinetic Trials

Bradley C. Johnston, ND; Ping Wu, MBBS; Edward Mills, DPH, MSc
Arch Pediatr Adolesc Med. 2005;159(7):690-692. doi:10.1001/archpedi.159.7.692.
Text Size: A A A
Published online


The use of natural health products (NHPs) among children and youth is on the rise and may be as high as 70% among certain pediatric populations (eg, children with chronic conditions: asthma, hyperactivity, cancer, cystic fibrosis, eating disorders).15 The potential for interactions between NHPs and drugs may be increased in pediatric populations because of altered metabolism and excretion. Natural health products administered in conjunction with conventional medications can affect drug pharmacokinetics (absorption, distribution, metabolism, and excretion). Herb-drug interactions are primarily due to altered biotransformation; in particular, herbs may cause induction (or inhibition) of the hepatic cytochrome P450 isozymes, rendering the index drug less (or more) active. We recently published a systematic review to determine the methodological quality of clinical trials examining the possible interactions of St John’s wort with conventional drugs.6 Since interactions between NHPs (ie, St John’s wort) and prescription medications in children are of increasing concern we have used similar methods to investigate this issue in children. Our objectives were to determine the prevalence of pharmacokinetic clinical investigations of NHP-drug interactions and their relevance to the pediatric populations.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario